Related Experiment Video
Updated: Jul 18, 2026
10:10
Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses
Published on: November 16, 2016
Interferon-gamma as a possible target in chronic asthma
Rakesh K Kumar1, Dianne C Webb, Cristan Herbert
1Department of Pathology, University of New South Wales, Sydney, Australia. R.Kumar@unsw.edu.au
Inflammation & Allergy Drug Targets
|December 16, 2006
Summary
Interferon-gamma (IFN-gamma) plays a key role in chronic asthma, suppressing airway hyperreactivity. Targeting IFN-gamma may be beneficial for managing chronic allergic asthma and its exacerbations.
Area of Science:
- Immunology
- Pulmonology
- Allergy Research
Background:
- The role of interferon-gamma (IFN-gamma) in asthma pathogenesis remains controversial.
- Asthma involves complex immune responses, including Th2 and potentially Th1 cytokines.
- Airway hyperreactivity (AHR) is a hallmark of asthma, but its underlying mechanisms can vary.
Purpose of the Study:
- To investigate the role of IFN-gamma in a chronic low-level allergic asthma model in mice.
- To explore the mechanisms of AHR in chronic versus acute asthma challenges.
- To determine the therapeutic potential of targeting IFN-gamma in chronic asthma.
Main Methods:
- Utilized a chronic low-level allergen challenge model in mice to mimic allergic asthma.
- Administered neutralizing antibodies against IFN-gamma to assess its impact on AHR.
- Quantified IFN-gamma-producing CD4+ T cells in peribronchial lymph nodes after chronic allergen challenge.
Main Results:
- Airway hyperreactivity in chronic asthma models was independent of typical Th2 cytokines.
- Administration of anti-IFN-gamma antibody suppressed AHR in the chronic model.
- IFN-gamma-producing CD4+ T cells were found in peribronchial lymph nodes following chronic, but not acute, allergen challenge.
- Anti-IFN-gamma treatment reduced the number of these IFN-gamma-producing CD4+ T cells.
Conclusions:
- IFN-gamma is implicated in the pathogenesis of AHR in chronic allergic asthma.
- A co-operative interaction between Th2 and Th1 cytokines, including IFN-gamma, likely contributes to asthma lesions.
- Therapeutic inhibition of IFN-gamma may be a viable strategy for managing chronic asthma and its acute exacerbations.
Related Concept Videos
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...